Julien Potet

5PUBLICATIONS
15CO-AUTHORS
Gene and molecular therapyFood safety, traceability, certification and authenticityChemotherapyMajor global burdens of diseaseToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 01, 2026
[Post-exposure prophylaxis against Ebola virus: arguments for expanding the role of monoclonal antibodies in a context of limited access].

|Jun 06, 2024
Debate-Pro: manufacturers should assess the long-term stability of their antivenoms.

Julien Potet

|Oct 26, 2021
Snakebites and COVID-19: two crises, one research and development opportunity.

Diogo Martins, Julien Potet, Isabela Ribeiro

|Aug 20, 2021
Control of visceral leishmaniasis in East Africa: fragile progress, new threats.

Elin Hoffmann Dahl, Hamdan Mustafa Hamdan, Lexson Mabrouk

|Jun 25, 2019
Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial.

Julien Potet, James Smith, Lachlan McIver

Pageof 1

Frequent Collaborators

1 joint publications

Elin Hoffmann Dahl

1 joint publications

Sultani Hadley Matendechero

1 joint publications

Tesfahun Bishaw Mengistie

1 joint publications

Mousab Siddig Elhag